Sunday, February 5, 2023

 

Conservative America Today

D A I L Y  N E W S  T O D A Y

FEBRUARY 5,  2 0 2 3


 


Biden's Inaction With SPY Balloon 'Very Concerning'

Rep. James Comer (R-KY), chairman of the House Oversight Committee, condemned President Joe...

⟶ Continue Reading

 

Just Patriots

Putin's SHOES May Show How Insecure He Is!

 

Presidential Wire

Adam Schiff Admits

Adam Schiff Admits "A Real Problem" Has Been Found

 

Read This Alert >>>

 ARIZONA TODAY

        LYLE J. RAPACKI, Ph.D.

                   ___________

 

 

Sunday –

February the 5th, 2023

 

 

While the entire Huckabee Show is available below, of particular interest is the interview Mike does with James O’Keefe founder and CEO of Project Veritas immediately following Huckabee’s monologue.  You will learn of a most recent undercover video/interview conducted by Project Veritas with Pfizer’s number #3 executive.  Most revealing how Pfizer strongly appears to be in collusion with the Global Elite to eradicate Americans.  The remainder of the Huckabee Show is also available for your review.

 

Lyle J. Rapacki, Ph.D.

_________________________

LYLE J. RAPACKI, Ph.D.

ARIZONA TODAY

Host and Commentator

 


 

Capital Hill News

Minnesota Judge Gives Serial Child Attacker Six-Month Sentence

A 20-year-old man convicted in a Minnesota court of criminal intercourse with two girls, aged four and nine, will spend...

Read More »

WND BREAKING NEWS

 


Faith communities pushed to 'fully comply' with LGBT agenda
 
Posted by WND News Services
 
It's now getting more perilous to be a Christian, as the dark powers that be are pushing 'full compliance' with the most perverse agenda that has ever come down the pike. Read more…

TRUMP TRAIN NEWS

 BREAKING: Third Chinese Spy Balloon “Operating Near U.S. Interests,” China Promises Response To Shootdown

 

RestoreAmericanGlory.com
DAILY NEWS | FEBRUARY 5, 2023


 



Trump Swears to OUTLAW This Practice!
Continue Reading 

TRUMP TRAIN NEWS

 Biden Failed To Shoot Down Chinese Spy Balloon 4 Months Ago

 




 
Learn more about Jeeng

Top U.S. Foe Makes Shocking Threat After America Dares To Fight Back   

Can Anything Stop Them?

READ MORE

Daily Caller

05 FEBRUARY 2023View in Browser
 
 
 

Please consider forwarding this email to your friends and family – they can sign up here today.

 

 
 
CHRISTIAN ADAMS: When Will California Realize Its Vote By Mail System Is A Total Disaster?
 
Step up

 

IT’S HAPPENING:
 
Fox News: Biden's ESG investment rules threaten your retirement savings
 
This is an emergency for people saving for retirement. Joe Biden’s devastating new rule allowing retirement planners to consider woke factors when making investment decisions for retirees JUST WENT INTO EFFECT… and we’re running out of time to strike it down!
 
The retirement savings of millions of Americans could be hanging in the balance and so we need your help straight away.

 

Lisa Haven News: New posts!

Here is your weekly digest.


‘China Balloon’ News Just Exploded—NEW Alert Goes Off & There’s a Potential Second One!!

By Lisa Haven Right now there is a Chinese surveillance balloon floating in our skies and the U.S. government is refusing to shoot it down. Read more…

by Lisa Haven on February 3rd, 2023

FDA Issues Alert, Announces Recall of Common Thyroid Medication, Mushrooms: All the Health Benefits, Revealed

 Int'l Interiors submits:

“The secret of being a bore is to tell everything.” 

VOLTAIRE

 

 

 

https://en.bcdn.biz/images/health/320x192/806ce645-a882-4c79-b464-282172a57bbb.jpg

Mushrooms: All the Health Benefits, Revealed

Show Content

 

 

 

FDA Issues Alert, Announces Recall of Common Thyroid Medication

HEALTH NEWS

Jack Phillips

Jack Phillips

Feb 3 2023

biggersmaller

Food and Drug Administration (FDA) headquarters in White Oak, Md., on Aug. 29, 2020. (Andrew Kelly/Reuters)

Food and Drug Administration (FDA) headquarters in White Oak, Md., on Aug. 29, 2020. (Andrew Kelly/Reuters)

 

The U.S. Food and Drug Administration (FDA) on Thursday announced the recall of a thyroidmedication after it was found that lots of the drug may be “subpotent.”

IBSA Pharma Inc. confirmed it is recalling Tirosint-SOL, or levothyroxine sodium, a medication used to treat an underactive thyroid gland. It said that the “voluntary recall has been initiated because these lots may be subpotent,” stated the announcement, published on the FDA’s website.

“The company’s analyses show a slight decrease below 95.0 percent of its labeled amount in levothyroxine sodium (T4) for some lots,” according to the recall notice. The recall doesn’t apply to Tirosint capsules.

People who take the recalled, subpotent drug could “experience signs and symptoms of hypothyroidism (underactive thyroid) which may include, fatigue, increased sensitivity to cold, constipation, dry skin, puffy face, hair loss, slow heart rate, depression, swelling of the thyroid gland and/or unexplained weight gain or difficulty losing weight,” the notice said.

Other side-effects, it said, may include “negative effects” on bone metabolism, reproductive function, cardiovascular function, growth and development, gastrointestinal function, cognitive function, emotional state, and glucose and lipid metabolism, the company said.

But so far, the company hasn’t received any reports of adverse events associated with the recalled lots of the drug.  The medication was distributed to the consumer level.

IBSA Pharma Inc., a Swiss-based company, said it is issuing notices to retailers, health care providers, and wholesalers to stop distribution of the recalled products.

 

 

The firm stipulated, however, that people “who are currently taking Tirosint-SOL should not discontinue use without contacting their healthcare provider for further guidance and/or replacement prescription,” according to the release. “Any patients including those who might be pregnant, newborn infants, or elderly patients, should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product,” it added.

The lot numbers, product codes, and expiration dates are available on the FDA’s website. The drug is a clear, colorless to slightly yellow solution that is supplied in a white 1 milliliter ampule.

According to health website WebMD, levothyroxine is used to treat an underactive thyroid gland and replaces or provides more thyroid hormone. For example, those who are treating thyroid cancer or who are in remission often have to take levothyroxine.

“Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation [or] medications or removed by surgery,” the website states. “Having enough thyroid hormone is important for normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer).”

 

/var/folders/bh/1mp54rt88xl42l008k8w8xq00000gn/T/com.microsoft.Outlook/WebArchiveCopyPasteTempFiles/default-user.png

TOM CZITRON

The Long-Term Negative Effects of ESG Will Be Catastrophic

SHARE*             READ MORE 

/var/folders/bh/1mp54rt88xl42l008k8w8xq00000gn/T/com.microsoft.Outlook/WebArchiveCopyPasteTempFiles/WEB_RobertMalone.jpg

DR. ROBERT MALONE

The Masking Debate Is Settled

 

logo

TRENDING: Pentagon Alerts: 2nd Spy Balloon Found!
› Massively...

THIS Sounds Like Biden Is Up To Something
› This could be disastrous...

CHINA RESPONDS To Spy Balloons In US Airspace!
› Seriously?...